earnings
AC
NASDAQ · ACXP
Acurx Pharmaceuticals, Inc.
Healthcare · Biotechnology
$1.02
Down-$0.05 (-4.67%)
Updated Nov 4, 2026, 2:07 AM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.38M
- P/E ratio
- -0.27
- Dividend yield
- 0.00%
- 52-week range
- $1.04 – $7.54
- Volume
- 207.24K
- Avg. volume
- 61.79K
Price performance · ACXP
ACXP price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
ACXP closed at $1.02 after 21 trading sessions, down 22.14% for the selected period.
- Last close
- $1.02
- Period change
- -22.14%
- Period low
- $1.02
- Period high
- $1.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $1.07 | $1.111 | $1.01 | $1.02 | 207.24K |
| Nov 2, 2026 | $1.08 | $1.12 | $1.0451 | $1.07 | 143.69K |
| Oct 30, 2026 | $1.09 | $1.1026 | $1.035 | $1.04 | 63.19K |
| Oct 29, 2026 | $1.06 | $1.11 | $1.06 | $1.07 | 64.57K |
| Oct 28, 2026 | $1.08 | $1.0801 | $1.05 | $1.07 | 61.18K |
| Oct 27, 2026 | $1.08 | $1.0961 | $1.05 | $1.06 | 58.37K |
| Oct 26, 2026 | $1.12 | $1.135 | $1.0809 | $1.085 | 64.39K |
| Oct 23, 2026 | $1.135 | $1.14 | $1.12 | $1.135 | 22.15K |
| Oct 22, 2026 | $1.16 | $1.185 | $1.14 | $1.14 | 26.54K |
| Oct 21, 2026 | $1.18 | $1.18 | $1.13 | $1.15 | 20.96K |
| Oct 20, 2026 | $1.16 | $1.18 | $1.115 | $1.14 | 68.3K |
| Oct 19, 2026 | $1.14 | $1.1458 | $1.10 | $1.14 | 51.1K |
| Oct 16, 2026 | $1.18 | $1.1896 | $1.0688 | $1.10 | 164.83K |
| Oct 15, 2026 | $1.20 | $1.2189 | $1.15 | $1.17 | 101.5K |
| Oct 14, 2026 | $1.20 | $1.2198 | $1.15 | $1.15 | 87.57K |
| Oct 13, 2026 | $1.29 | $1.29 | $1.20 | $1.20 | 99.67K |
| Oct 12, 2026 | $1.28 | $1.30 | $1.25 | $1.28 | 80.82K |
| Oct 9, 2026 | $1.24 | $1.28 | $1.24 | $1.27 | 41.15K |
| Oct 8, 2026 | $1.281 | $1.281 | $1.24 | $1.25 | 74.94K |
| Oct 7, 2026 | $1.32 | $1.3299 | $1.28 | $1.30 | 78.04K |
| Oct 6, 2026 | $1.30 | $1.33 | $1.28 | $1.31 | 42.2K |
Latest ACXP news
The latest Smart Investors Daily articles mentioning ACXP.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

